Shouyao Holdings (Beijing) Co., LTD. (SHA:688197)

China flag China · Delayed Price · Currency is CNY
38.85
+0.33 (0.86%)
At close: Feb 13, 2026
Market Cap5.78B +36.2%
Revenue (ttm)8.67M +119.9%
Net Income-128.83M
EPS-0.87
Shares Out148.72M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume828,586
Average Volume1,073,364
Open38.39
Previous Close38.52
Day's Range38.39 - 39.71
52-Week Range25.52 - 56.86
Beta1.01
RSI55.02
Earnings DateMar 14, 2026

About SHA:688197

Shouyao Holdings (Beijing) Co., LTD. engages in the research, development, and production of innovative drugs in China. The company offers drugs for various indications, including non-small cell lung cancer, lymphoma, hepatocellular carcinoma, pancreatic cancer, breast cancer, ovarian cancer, thyroid cancer, leukemia, and diabetes. The company was founded in 2016 and is headquartered in Beijing, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2016
Employees 172
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688197
Full Company Profile

Financial Performance

In 2025, SHA:688197's revenue was 8.67 million, an increase of 119.88% compared to the previous year's 3.94 million. Losses were -128.83 million, -39.21% less than in 2024.

Financial Statements